BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Healthtrust
US Department of Justice
Citi
Fuji
Cantor Fitzgerald
Dow
Deloitte
Mallinckrodt
Chinese Patent Office

Generated: January 20, 2018

DrugPatentWatch Database Preview

KEFLIN Drug Profile

« Back to Dashboard

Which patents cover Keflin, and when can generic versions of Keflin launch?

Keflin is a drug marketed by Lilly and is included in two NDAs.

The generic ingredient in KEFLIN is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
Drug patent expirations by year for KEFLIN
Medical Subject Heading (MeSH) Categories for KEFLIN

US Patents and Regulatory Information for KEFLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly KEFLIN cephalothin sodium INJECTABLE;INJECTION 050482-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly KEFLIN cephalothin sodium INJECTABLE;INJECTION 050482-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly KEFLIN cephalothin sodium INJECTABLE;INJECTION 050482-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly KEFLIN cephalothin sodium INJECTABLE;INJECTION 050482-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly KEFLIN IN PLASTIC CONTAINER cephalothin sodium INJECTABLE;INJECTION 062549-002 Sep 10, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly KEFLIN IN PLASTIC CONTAINER cephalothin sodium INJECTABLE;INJECTION 062549-001 Sep 10, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Cerilliant
Cantor Fitzgerald
Covington
McKesson
Chubb
UBS
Fish and Richardson
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot